The Rebirth of a Phoenix

Ovarian Cancers Are Addicted to ErbB-3

Gordon Mills, Yosef Yarden

Research output: Contribution to journalShort survey

12 Citations (Scopus)

Abstract

Several cancer drugs intercept the ErbB family receptors EGFR (ErbB-1) and HER2 (ErbB-2). However, the therapeutic value of targeting ErbB-3 has been less clear. A report in this issue of Cancer Cell by Sheng et al. renews hopes that intercepting ErbB-3-mediated autocrine loops bears potential for treatment of ovarian cancer.

Original languageEnglish (US)
Pages (from-to)217-218
Number of pages2
JournalCancer Cell
Volume17
Issue number3
DOIs
StatePublished - Mar 16 2010
Externally publishedYes

Fingerprint

Ovarian Neoplasms
Neoplasms
Pharmaceutical Preparations
Therapeutics
ErbB Receptors

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Oncology

Cite this

The Rebirth of a Phoenix : Ovarian Cancers Are Addicted to ErbB-3. / Mills, Gordon; Yarden, Yosef.

In: Cancer Cell, Vol. 17, No. 3, 16.03.2010, p. 217-218.

Research output: Contribution to journalShort survey

Mills, Gordon ; Yarden, Yosef. / The Rebirth of a Phoenix : Ovarian Cancers Are Addicted to ErbB-3. In: Cancer Cell. 2010 ; Vol. 17, No. 3. pp. 217-218.
@article{c8274366539041d2b2aeba876d1f441b,
title = "The Rebirth of a Phoenix: Ovarian Cancers Are Addicted to ErbB-3",
abstract = "Several cancer drugs intercept the ErbB family receptors EGFR (ErbB-1) and HER2 (ErbB-2). However, the therapeutic value of targeting ErbB-3 has been less clear. A report in this issue of Cancer Cell by Sheng et al. renews hopes that intercepting ErbB-3-mediated autocrine loops bears potential for treatment of ovarian cancer.",
author = "Gordon Mills and Yosef Yarden",
year = "2010",
month = "3",
day = "16",
doi = "10.1016/j.ccr.2010.02.023",
language = "English (US)",
volume = "17",
pages = "217--218",
journal = "Cancer Cell",
issn = "1535-6108",
publisher = "Cell Press",
number = "3",

}

TY - JOUR

T1 - The Rebirth of a Phoenix

T2 - Ovarian Cancers Are Addicted to ErbB-3

AU - Mills, Gordon

AU - Yarden, Yosef

PY - 2010/3/16

Y1 - 2010/3/16

N2 - Several cancer drugs intercept the ErbB family receptors EGFR (ErbB-1) and HER2 (ErbB-2). However, the therapeutic value of targeting ErbB-3 has been less clear. A report in this issue of Cancer Cell by Sheng et al. renews hopes that intercepting ErbB-3-mediated autocrine loops bears potential for treatment of ovarian cancer.

AB - Several cancer drugs intercept the ErbB family receptors EGFR (ErbB-1) and HER2 (ErbB-2). However, the therapeutic value of targeting ErbB-3 has been less clear. A report in this issue of Cancer Cell by Sheng et al. renews hopes that intercepting ErbB-3-mediated autocrine loops bears potential for treatment of ovarian cancer.

UR - http://www.scopus.com/inward/record.url?scp=77649285474&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77649285474&partnerID=8YFLogxK

U2 - 10.1016/j.ccr.2010.02.023

DO - 10.1016/j.ccr.2010.02.023

M3 - Short survey

VL - 17

SP - 217

EP - 218

JO - Cancer Cell

JF - Cancer Cell

SN - 1535-6108

IS - 3

ER -